Comprehensive approach to analyzing rare genetic variants.

Recent findings suggest that rare variants play an important role in both monogenic and common diseases. Due to their rarity, however, it remains unclear how to appropriately analyze the association between such variants and disease. A common approach entails combining rare variants together based o...

Full description

Bibliographic Details
Main Authors: Thomas J Hoffmann, Nicholas J Marini, John S Witte
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2010-11-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC2972202?pdf=render
id doaj-361747a4eb2e4c39befbd937b1966847
record_format Article
spelling doaj-361747a4eb2e4c39befbd937b19668472020-11-24T20:45:12ZengPublic Library of Science (PLoS)PLoS ONE1932-62032010-11-01511e1358410.1371/journal.pone.0013584Comprehensive approach to analyzing rare genetic variants.Thomas J HoffmannNicholas J MariniJohn S WitteRecent findings suggest that rare variants play an important role in both monogenic and common diseases. Due to their rarity, however, it remains unclear how to appropriately analyze the association between such variants and disease. A common approach entails combining rare variants together based on a priori information and analyzing them as a single group. Here one must make some assumptions about what to aggregate. Instead, we propose two approaches to empirically determine the most efficient grouping of rare variants. The first considers multiple possible groupings using existing information. The second is an agnostic "step-up" approach that determines an optimal grouping of rare variants analytically and does not rely on prior information. To evaluate these approaches, we undertook a simulation study using sequence data from genes in the one-carbon folate metabolic pathway. Our results show that using prior information to group rare variants is advantageous only when information is quite accurate, but the step-up approach works well across a broad range of plausible scenarios. This agnostic approach allows one to efficiently analyze the association between rare variants and disease while avoiding assumptions required by other approaches for grouping such variants.http://europepmc.org/articles/PMC2972202?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Thomas J Hoffmann
Nicholas J Marini
John S Witte
spellingShingle Thomas J Hoffmann
Nicholas J Marini
John S Witte
Comprehensive approach to analyzing rare genetic variants.
PLoS ONE
author_facet Thomas J Hoffmann
Nicholas J Marini
John S Witte
author_sort Thomas J Hoffmann
title Comprehensive approach to analyzing rare genetic variants.
title_short Comprehensive approach to analyzing rare genetic variants.
title_full Comprehensive approach to analyzing rare genetic variants.
title_fullStr Comprehensive approach to analyzing rare genetic variants.
title_full_unstemmed Comprehensive approach to analyzing rare genetic variants.
title_sort comprehensive approach to analyzing rare genetic variants.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2010-11-01
description Recent findings suggest that rare variants play an important role in both monogenic and common diseases. Due to their rarity, however, it remains unclear how to appropriately analyze the association between such variants and disease. A common approach entails combining rare variants together based on a priori information and analyzing them as a single group. Here one must make some assumptions about what to aggregate. Instead, we propose two approaches to empirically determine the most efficient grouping of rare variants. The first considers multiple possible groupings using existing information. The second is an agnostic "step-up" approach that determines an optimal grouping of rare variants analytically and does not rely on prior information. To evaluate these approaches, we undertook a simulation study using sequence data from genes in the one-carbon folate metabolic pathway. Our results show that using prior information to group rare variants is advantageous only when information is quite accurate, but the step-up approach works well across a broad range of plausible scenarios. This agnostic approach allows one to efficiently analyze the association between rare variants and disease while avoiding assumptions required by other approaches for grouping such variants.
url http://europepmc.org/articles/PMC2972202?pdf=render
work_keys_str_mv AT thomasjhoffmann comprehensiveapproachtoanalyzingraregeneticvariants
AT nicholasjmarini comprehensiveapproachtoanalyzingraregeneticvariants
AT johnswitte comprehensiveapproachtoanalyzingraregeneticvariants
_version_ 1716815061241036800